"
Team:UCL
From 2013.igem.org
(Difference between revisions)
| Line 86: | Line 86: | ||
<div class="large_left" style="height:298px;"> | <div class="large_left" style="height:298px;"> | ||
| - | <h1> | + | <h1>Team Abstract</h1> |
<p> | <p> | ||
| - | + | The UCL iGEM team of 2013 plans to create a potential treatment for AB plaque related diseases, notably Alzheimer's, the most common form of dementia which costs the UK National Health Service more then Cancer and Stroke treatment combined. The aim is to use ''Microglial'' cells which are part of the brains natural immune defence and subsequently modify these cells to target and break down AB Plaques, which may delay the onset of Alzheimer's disease in patients. | |
</p> | </p> | ||
Revision as of 13:55, 11 July 2013
Team Abstract
The UCL iGEM team of 2013 plans to create a potential treatment for AB plaque related diseases, notably Alzheimer's, the most common form of dementia which costs the UK National Health Service more then Cancer and Stroke treatment combined. The aim is to use ''Microglial'' cells which are part of the brains natural immune defence and subsequently modify these cells to target and break down AB Plaques, which may delay the onset of Alzheimer's disease in patients.
This first row will provide highlights from the current week, with some panels containing an entire image, etc.
This second row will provide highlights from the previous week, with some panels containing an entire image, etc.
